Affiliation:
1. Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, Indiana 46285.
Abstract
(1,3)-beta-D-Glucan synthase, a major cell wall synthesis enzyme, is the target of antifungal drugs of the lipopeptide class. Aspergillus fumigatus (1,3)-beta-D-glucan synthase was prepared and its activity was measured by incorporation of [14C]glucose from UDP-[U-14C]glucose into an insoluble polymer in the presence of alpha-amylase. Solubilization of the (1,3)-beta-D-glucan synthase was attempted with several detergents, and the maximum percent solubilization was obtained with a polyoxyethylene ether detergent, W-1. Up to 70% of enzyme activity and 50% of total protein were recovered when 1-mg/ml membrane preparations were extracted with 0.045% W-1 at 4 degrees C overnight. Confirmation of the presence of a (1,3)-beta-D-glucose polymer synthesized by this glucan synthase was done by three methods. The first was enzymatic end product degradation by alpha-amylase (no degradation) and beta-glucanase (85 to 95% degradation). The second was gas chromatography-mass spectroscopy analysis of the partially methylated alditol acetate derivatives prepared from total carbohydrate polymers present in the sample. This method identified the presence of (1,3)- and (1,2)-glucosidic linkages. The third was high-performance anion exchange chromatography of radioactive oligosaccharides. This method allowed differentiation of the newly synthesized, radioactive polymers from the contaminating carbohydrates already present in the preparation. The results showed that the polymer synthesized comprised oligosaccharides consistent with beta-(1,3)-linked sugars. Maximal inhibition of the (1,3)-beta-D-glucan synthase by the lipopeptide antifungal agent cilofungin was 80%. Dose-response experiments with this inhibitor showed that the solubilized enzyme was maximally inhibited at a cilofungin concentration of 1.25 microgram/ml and showed <5% inhibition at 0.02 microgram/ml. The apparent K(m) (K(m app)) for the solubilized glucan synthase was 400 +/- 80 microM, and the apparent K(i) (K(i app)) for cilofungin was 0.19 +/- 0.03 microM. Inhibition of A.fumigatus (1,3)-beta-D-glucan synthase with cilofungin was noncompetitive, as it was for the Candida albicans (1,3)-beta-D-glucan synthase.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference24 articles.
1. Cell wall chemistry, morphogenesis, and taxonomy of fungi. Annu;Bartnicki-Garcia S.;Rev. Microbiol.,1968
2. Correlation of cilofungin in vivo efficacy with its activity against Aspergillusfumigatus (1-3)-,B-D-glucan synthase;Beaulieu D.;FEMS Microbiol. Lett.,1993
3. Beaulieu D. D. Zeckner J. Tang R. S. Gordee and T. R. Parr Jr. 1992. Cilofungin effectiveness in murine Aspergillus fumigatus infections correlates with its inhibition of B-(1-3) glucan synthase but not with its minimum inhibitory concentrations abstr. F78 p. 511. Abstr. 92nd Gen. Meet. Am. Soc. Microbiol. 1992. American Society for Microbiology Washington D.C.
4. Characterization of Aspergillus nidulans mutants deficient in cell wall chitin or glucan;Borgia P. T.;J. Bacteriol.,1992
5. Adherence and receptor relationships of Candida albicans;Calderone R. A.;Microbiol. Rev.,1991
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献